REPROCELL News

Stem cell and drug discovery scientists around the world are using REPROCELL’s services and products in their preclinical and clinical research.

About REPROCELL

Make an inquiry

REPROCELL join Medicines Discovery Catapult’s Virtual R&D network to accelerate drug development

ROSLINCT and REPROCELL awarded £1.2 million from Innovate UK for clinical-grade stem cell production

REPROCELL’s Dr David Bunton on April 2018 Trade Mission to China with Scottish First Minister Nicola Sturgeon

Derek Mackay, SNP Cabinet Secretary for Finance and the Constitution, visits REPROCELL Europe, Glasgow

REPROCELL’s David Bunton addresses the Scottish Parliament

Patient-derived tumor organoids recapitulate clinical treatments

REPROCELL Chooses Science Exchange as the Preferred Partner to Increase Accessibility of its Predictive Drug Discovery Services

Article by Dr David Bunton (co-authored) in the European Pharmaceutical Review, Autumn 2017

Nicola Sturgeon: interview at the official opening of REPROCELL’s Centre for Predictive Drug Discovery (YouTube video)

Press Release: Nicola Sturgeon, First Minister of Scotland, opens REPROCELL European Headquarters in Glasgow

REPROCELL Europe’s CEO Dr David Bunton presented at NC3Rs workshop: Human tissue models for cancer research

REPROCELL Inc CEO meets with Scottish Cabinet Secretary Fiona Hyslop in Japan

Scottish Enterprise Association Honours REPROCELL with Annual Awards Nomination

Announcement on the initiation of a new business from the collaboration and commercialization agreement with Steminent Biotherapeutics Inc. for cell therapy

Latest Proteon and Biopta publication demonstrates Proteon's Vonapanitase effects in human cephalic veins

Proteon and Biopta publication shows promising nonclinical results on Proteon's Vonapanitase

REPROCELL acquires Biopta to expand its drug discovery services

Biopta co-authors research in the European Respiratory Journal

REPROCELL announces publication of a research report on “3D Skin Model Construction,” submitted to the International Scientific Journal “Molecular Cancer Therapeutics” by REPROCELL and others

New paper demonstrates formation of spontaneously active neuronal networks by stem cell derived neurons in 3D Alvetex Scaffold culture system

Subscribe to receive updates